Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Mercedes Latorre Sánchez"'
Autor:
Carlos Alventosa Mateu, María Dolores Ocete Mochón, Juan José Urquijo Ponce, Mercedes Latorre Sánchez, Inmaculada Castelló Miralles, Miguel García Deltoro, Enrique Ortega González, María José Bonet Igual, Concepción Gimeno Cardona, Moisés Diago Madrid
Publikováno v:
Annals of Hepatology, Vol 28, Iss , Pp 100938- (2023)
Introduction and Objectives: Strategies to simplify the care circuit for patients with the hepatitis C virus (HCV) are vital to achieving its eradication. To achieve this aim, we introduced an electronic system of HCV serology detection to link diagn
Externí odkaz:
https://doaj.org/article/c62949bb85d34e6ebb4f379ebbdf0fe5
Autor:
Carlos Alventosa Mateu, Juan José Urquijo Ponce, Armando Mena Durán, Mercedes Latorre Sánchez, Inmaculada Castelló Miralles, Mariano Linares García, Moisés Diago
Publikováno v:
Revista Española de Enfermedades Digestivas.
Autor:
Carlos, Alventosa Mateu, María Dolores, Ocete Mochón, Juan José, Urquijo Ponce, Mercedes, Latorre Sánchez, Inmaculada, Castelló Miralles, Miguel, García Deltoro, Enrique, Ortega González, María José, Bonet Igual, Concepción, Gimeno Cardona, Moisés, Diago Madrid
Publikováno v:
Revista Española de Enfermedades Digestivas.
Simplification strategies for the care circuit of patients with hepatitis C virus (HCV) are key to achieve eradication. We set up an electronic identification system for HCV serology to link diagnosis to specialist management aiming at reducing patie
Autor:
Carlos Alventosa Mateu, Salvador Benlloch Pérez, Miguel García Deltoro, Mercedes Latorre Sánchez, Francisco Sanz Herrero, Juan José Urquijo Ponce, Moisés Diago Madrid, Concepción Gimeno Cardona, María Dolores Ocete Mochón, Francesc Puchades Gimeno
Publikováno v:
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 113(12)
INTRODUCTION: Abnormal liver biochemistry (ALB) is correlated with increased clinical involvement or severity in COVID-19, but its prognostic implications have not been studied extensively. Our aim is to determine whether ALB is a risk factor for an
Autor:
Carlos Alventosa Mateu, Elena Guillen Botaya, Cecilia Albert-Antequera, Irene Perez Alvarez, Alejandro Fernandez Soro, Eva Sanchez Ramos, Salvador Benlloch, Juan Jose Urquijo Ponce, Francesc Puchades Gimeno, Francisco Sanz Herrero, Miguel García Deltoro, Mercedes Latorre Sánchez, Inmaculada Castelló Miralles, Dolores Ocete Mochon, Concepcion Gimeno Cardona, Moises Diago
Publikováno v:
Journal of Hepatology. 77:S222
Autor:
Carlos, Alventosa Mateu, Lydia, Plana Campos, Laura, Larrey Ruíz, Raquel, Acedo Mayordomo, Laura, Sanchís Artero, Laura, Peño Muñoz, Paola Concepción, Núñez Martínez, Génesis Aurora, Castillo López, Mercedes, Latorre Sánchez, Juan José, Urquijo Ponce, Moisés, Diago Madrid, Javier Sempere, García-Argüelles
Publikováno v:
Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru. 37(1)
Leptospirosis disease is caused by the spirochete Leptospira. It is a worldwide distribution zoonosis, with predominance in the tropics. In Spain, it is not frequent but some cases have been noticed especially in humid areas surrounded by rivers, lak
Autor:
José María Huguet Malavés, Luis Ferrer Arranz, Isabel Rodríguez García, Mercedes Latorre Sánchez, Lucía Ruiz Sánchez, Juan Antonio Tuset Ruiz, Alica Tomé Toyosato, Ana Belén Durá Ayet, Enrique Medina Chuliá
Publikováno v:
Gastroenterología y Hepatología. 31:280-284
Resumen Introduccion La ciclosporina (CyA) intravenosa (i.v.) ha demostrado ser eficaz en el control de los brotes agudos graves de colitis ulcerosa que no responden a esteroides i.v. Tras la respuesta inicial a la CyA i.v., se han propuesto dos alte
Autor:
José María, Huguet Malavés, Lucía, Ruiz Sánchez, Ana Belén, Durá Ayet, Isabel, Rodríguez García, Mercedes, Latorre Sánchez, Luis, Ferrer Arranz, Juan Antonio, Tuset Ruiz, Alica, Tomé Toyosato, Enrique, Medina Chuliá
Publikováno v:
Gastroenterologia y hepatologia. 31(5)
Intravenous (i.v.) cyclosporine (CsA) has proved effective in controlling acute attacks of ulcerative colitis unresponsive to IV steroids. After the initial response to i.v. CsA, two alternatives for maintaining remission have been proposed: either d